ARID1A and endometrial endometrioid adenocarcinoma: This finding was further corroborated in our in vivo studies, wherein ARID1A loss was correlated with DUSP4 loss in the uterine epithelium of genetically engineered model mice and in human uterine endometrioid carcinoma tissues.